The comparison of methods for the quantification of the pharmaceutical substance bismuth subsalicylate by UV-spectrophotometry and stripping voltammetry
https://doi.org/10.31549/2542-1174-2021-1-73-80
Abstract
The results of a comparative study of methods for the quantitative determination of the active pharmaceutical substance (APS) bismuth subsalicylate by UV-spectrophotometry and stripping voltammetry (SV) are presented. Partial validation of the compared methods was carried out according to the following characteristics: linearity, detection limit, limit of quantification, accuracy. In the course of linearity assessment, the values of the correlation coefficient of the methods were established — 0.9987 for UV-spectrophotometry and 0.9982 for SV. The detection limit and the limit of quantification for UV-spectrophotometry were 2.35 and 7.12 Bg/ml respectively, for SV — 1.16 and 3.52 Bg respectively. The accuracy was determined by the constant term of the linearity equation, which was 3.34% of the interval’s middle value when analyzed by UV-spectrophotometry and 1.93% by SV.
Thus, both methods can be used for the quantitative determination of the APS of bismuth subsalicylate; however, due to the fact that the content of bismuth is mainly determined in this case, the SV method is more preferable since it allows analyzing this particular part of the molecule.
About the Authors
A. A. Vizer
Novosibirsk State Medical University
Russian Federation
Russian Federation
E. A. Ivanovskaya
Novosibirsk State Medical University
Russian Federation
Russian Federation
A. V. Ligostaev
Novosibirsk State Medical University
Russian Federation
Russian Federation
References
1. Bierer D.W. (1998). Bismuth subsalicylate: history, chemistry, and safety. Rev. Infect. Dis., 12 (1), S3-S8.
2. McQuaid K.R. (2014). Drugs used in the treatment of gastrointestinal diseases (Ch. 62). In Katzung B.G., Trevor A.J. (eds.). Basic and Clinical Pharmacology. 13th ed. San Francis^, McGraw-Hill Medical.
3. Bismuth subsalicylate 1495 (01/2008) (2016). In European Pharmacopoeia 9.0. Strasbourg: Directorate for the Quality of Medicines and Health Care, Council of Europe. 2, p. 1854.
4. The United States Pharmacopeia 41. The National Formulary 36 (2018). Rockville (MD), 1, pp. 536-539.
5. Shinde N.S., Mahajan H.A., Kashid L.M., Mokashi S., Kolhe K.G. (2017). Assessment of electro-analytical behaviour and method validation of bismuth subsalicylate in pharmaceutical formulation by differential pulse polarography. J. Chemist. Chem. Sci., 7 (10), 752-762.
6. State Pharmacopoeia of the Russian Federation. 14th ed. (2018). Moscow. In Russ.
7. Vania A., Hardeman A., Halasz I. et al. (2011). Mechanosynthesis of the metallodrug bismuth subsalicylate from Bi2O3 and structure of bismuth salicylate without auxillary organic ligands. Angew. Chem. Int. Ed., 50, 7858-7861.
Review
For citations:
Vizer A.A., Ivanovskaya E.A., Ligostaev A.V. The comparison of methods for the quantification of the pharmaceutical substance bismuth subsalicylate by UV-spectrophotometry and stripping voltammetry. Journal of Siberian Medical Sciences. 2021;(1):73-80. https://doi.org/10.31549/2542-1174-2021-1-73-80
Views:
192
Email this article 